Northwire Canada EditionMonday, July 13, 2026
Sign inSubscribe
Northwire
⌕
S 0.160 +3.2% OMI 0.315 +0.0% BMM 4.02 +5.8% CGD 0.630 +10.5% OCG 0.280 +0.0% CAMB 0.990 −1.0% HMR 0.600 −3.2% GOFL 0.025 +0.0% SIG 1.01 −1.9% SGQ 0.300 +0.0% AMCO 0.220 −12.0% TRS 0.055 +0.0% RRI 0.265 +0.0% GAL 0.390 −2.5% LIB 0.800 −12.1% SMY 0.290 +23.4% S 0.160 +3.2% OMI 0.315 +0.0% BMM 4.02 +5.8% CGD 0.630 +10.5% OCG 0.280 +0.0% CAMB 0.990 −1.0% HMR 0.600 −3.2% GOFL 0.025 +0.0% SIG 1.01 −1.9% SGQ 0.300 +0.0% AMCO 0.220 −12.0% TRS 0.055 +0.0% RRI 0.265 +0.0% GAL 0.390 −2.5% LIB 0.800 −12.1% SMY 0.290 +23.4%
Management

Organigram Announces Appointment of Chief Executive Officer

By The Northwire Desk — AI Analysis Nov 25, 2025 · 06:00 OGI · 2.2 ORGANIGRAM GLOBAL INC.
OGI · Price

Executive Summary

  • Organigram Global Inc. announced the appointment of James Yamanaka, former Global Head of Strategy at British American Tobacco, as its new CEO effective around January 15 2026.
  • Yamanaka will also join the Board of Directors upon assuming the CEO role; interim executive chair Peter Amirault will oversee day‑to‑day management until then.
  • The appointment is positioned to support Organigram’s strategy of expanding its international presence and accelerating growth in the global cannabis market.

Key Details

  • New CEO: James Yamanaka, previously Global Head of Strategy at BAT; over 20 years of experience in strategy and general management across Europe and Asia.
  • Effective Date: On or about January 15 2026 (subject to immigration and security clearance procedures).
  • Board Membership: Yamanaka will become a member of Organigram’s Board of Directors when he assumes the CEO role.
  • Interim Management:
  • Peter Amirault, current Board chairman, appointed Executive Chair effective December 1 2025 to oversee daily operations until Yamanaka starts.
  • Geoff Machum, chair of the Governance, Nominating and Sustainability Committee, will serve as Independent Lead Director during the interim period.
  • Strategic Rationale: Management highlighted Yamanaka’s track record in driving international growth, building high‑performing teams, and delivering results—key to Organigram’s ambition to become a global leader in cannabis.
  • CEO Quote: “I am thrilled to take on this new challenge… I look forward to building an international presence on Organigram’s strong foundation of high‑quality products, trusted brands, and a commitment to industry‑leading innovation.” – James Yamanaka.
  • Chair Quote: “James’ history of driving strong international growth aligns perfectly with Organigram’s global aspirations.” – Peter Amirault.

Notable Quotes

  • “We are excited to have James join the Organigram team,” said Peter Amirault, Board Chairman and interim Executive Chair.
  • “I have watched Organigram evolve into Canada’s number one recreational cannabis company by market share and believe it is well positioned to become a global leader in the cannabis industry.” – James Yamanaka.
Read the original news release →

More from ORGANIGRAM GLOBAL INC.

May 14, 2026 · 08:45

Organigram Left Watching as European Cannabis Boom Accelerates, Q2 Miss Deepens Share Slide

M&A / Property May 12, 2026 · 06:00

Organigram’s core Canadian business stumbles into the red just as its landmark Sanity Group deal closes, leaving investors to wonder if the European cure will be enough to offset domestic decay.

Earnings Apr 15, 2026 · 12:03

Organigram Executes Europe Pivot as BAT Deal Closes, Dilution Looms

Financings Mar 30, 2026 · 20:30

Organigram Clears Final Hurdle for Sanity Acquisition as Dilution and Cash Constraints Loom

Financings Mar 23, 2026 · 14:07

Organigram garners ISS support for Sanity transaction

M&A / Property Mar 23, 2026 · 06:00

Organigram Announces Independent Proxy Advisory Firm ISS Recommends Organigram Shareholders Vote FOR the Acquisition of Sanity Group GmbH

M&A / Property